Currently available treatment for patients suffering from AD involves AChE inhibitors such as rivastigmine, donepezil, and galantamine, which avoid the hydrolysis of Ach, thereby increasing its concentration [27,28]. The gene discussed is ACHE; the disease is Alzheimer disease.